Neola Medical AB (OSTO:NEOLA) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Neola Medical AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Neola Medical AB's Free Cash Flow for the three months ended in Sep. 2024 was kr-3.22 Mil. Neola Medical AB's Revenue for the three months ended in Sep. 2024 was kr0.00 Mil. Therefore, Neola Medical AB's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Neola Medical AB's current FCF Yield % is -5.32%.

The historical rank and industry rank for Neola Medical AB's FCF Margin % or its related term are showing as below:

During the past 6 years, the highest FCF Margin % of Neola Medical AB was -465.04%. The lowest was -28150.00%. And the median was -14702.21%.

OSTO:NEOLA's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -4.43
* Ranked among companies with meaningful FCF Margin % only.

Neola Medical AB FCF Margin % Historical Data

The historical data trend for Neola Medical AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neola Medical AB FCF Margin % Chart

Neola Medical AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-28,150.00

-26,612.90

-2,791.52

Neola Medical AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Neola Medical AB's FCF Margin %

For the Medical Devices subindustry, Neola Medical AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neola Medical AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's FCF Margin % falls into.

Neola Medical AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Neola Medical AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-18.847	/	0
	=	%

Neola Medical AB's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-3.222	/	0
	=	%

Neola Medical AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Neola Medical AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neola Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neola Medical AB (OSTO:NEOLA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 27, Ideon Science Park, Gateway 9th fl oor, Lund, SWE, 223 63

Website

https://www.neolamedical.se

Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.

Neola Medical AB Headlines

No Headlines